Sun Pharmaceutical Industries is currently trading at Rs. 680.10, up by 0.50 points or 0.07% from its previous closing of Rs. 679.60 on the BSE.
The scrip opened at Rs. 681.00 and has touched a high and low of Rs. 684.70 and Rs. 678.50 respectively. So far 55024 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 898.00 on 23-Feb-2016 and a 52 week low of Rs. 572.40 on 09-Nov-2016.
Last one week high and low of the scrip stood at Rs. 686.60 and Rs. 621.05 respectively. The current market cap of the company is Rs. 163391.73 crore.
The promoters holding in the company stood at 54.39%, while institutions and non-institutions held 33.97% and 11.65% respectively.
Sun Pharmaceutical Industries (Sun Pharma) has reportedly opened its first production facility in Egypt, signalling growing business ties between India and the key Middle East nation. The company has invested around $12.5 million for this new production unit in Egypt.
Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable the company to deliver quality products in a timely manner at affordable prices. It provides high quality, affordable medicines trusted by customers and patients in over 150 countries across the world.